We are pleased that Sanofi has recognized the potential of Curadigm's Nanoprimer to improve the efficacy of product candidates in their gene therapy ...
https://www.google.com/url?rct=j&sa=t&url=https://www.businesswire.com/news/home/20210125005694/en/Nanobiotix-Subsidiary-Curadigm-Secures-New-Collaboration-Agreement-With-Sanofi-Focused-on-Gene-Therapy-Pipeline&ct=ga&cd=CAIyGmEyNDJjNTAxZWU3OTQyNzI6Y29tOmVuOlVT&usg=AFQjCNGB8FfX4EvDS7D8RBKc43ssiVq-uw
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.